Answers are grounded in this paper and cite their sources.
Reveals diagnostic challenges of invasive pulmonary aspergillosis in COPD patients receiving immunotherapy, indicating need for careful assessment.
Checkpoint inhibitor‐associated pneumonitis complicated by invasive pulmonary aspergillosis represents a diagnostic challenge in ICI‐treated patients, particularly those with COPD receiving corticosteroid therapy. Persistent or worsening respiratory abnormalities despite immunosuppressive treatment should prompt reassessment for superimposed fungal infection, including bronchoscopy, BALF analysis, and microbiologic testing to facilitate diagnosis and targeted therapy.
No takes yet. Share an insight, caveat, or question.
Elendu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: